ATE404692T1 - Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen. - Google Patents
Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen.Info
- Publication number
- ATE404692T1 ATE404692T1 AT04743090T AT04743090T ATE404692T1 AT E404692 T1 ATE404692 T1 AT E404692T1 AT 04743090 T AT04743090 T AT 04743090T AT 04743090 T AT04743090 T AT 04743090T AT E404692 T1 ATE404692 T1 AT E404692T1
- Authority
- AT
- Austria
- Prior art keywords
- tau protein
- fyn
- candidate
- phosphatase
- site
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0314943.2A GB0314943D0 (en) | 2003-06-25 | 2003-06-25 | Screening methods |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE404692T1 true ATE404692T1 (de) | 2008-08-15 |
Family
ID=27637418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04743090T ATE404692T1 (de) | 2003-06-25 | 2004-06-25 | Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen. |
Country Status (11)
Country | Link |
---|---|
US (2) | US8822171B1 (de) |
EP (1) | EP1636375B1 (de) |
JP (2) | JP5688747B2 (de) |
AT (1) | ATE404692T1 (de) |
AU (1) | AU2004252273B2 (de) |
CA (2) | CA2527437C (de) |
DE (1) | DE602004015791D1 (de) |
DK (1) | DK1636375T3 (de) |
ES (1) | ES2313032T3 (de) |
GB (1) | GB0314943D0 (de) |
WO (1) | WO2005001114A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0314943D0 (en) * | 2003-06-25 | 2003-07-30 | Proteome Sciences Plc | Screening methods |
AU2005253776B8 (en) * | 2004-06-21 | 2012-02-02 | King's College London | Screening methods using c-Abl, Fyn and Syk in combination with tau protein |
JP4522910B2 (ja) * | 2005-05-30 | 2010-08-11 | 株式会社日立ハイテクノロジーズ | 質量分析方法及び質量分析装置 |
JP5518479B2 (ja) * | 2006-10-25 | 2014-06-11 | ザ ロックフェラー ユニヴァーシティ | Aβ関連障害の処置のための方法およびその組成物 |
US20110294144A1 (en) * | 2008-02-12 | 2011-12-01 | Kenichi Noguchi | Screening method |
GB0903913D0 (en) * | 2009-03-06 | 2009-04-22 | Medical Res Council | Compositions and methods |
EP2651405A2 (de) | 2010-12-14 | 2013-10-23 | Electrophoretics Limited | Casein-kinase-1 (ck1)-inhibitoren |
WO2014055413A2 (en) * | 2012-10-02 | 2014-04-10 | Bloodcenter Research Foundation | A method of providing cellular therapy using modified natural killer cells or t lymphocytes |
RU2016132574A (ru) | 2014-01-09 | 2018-02-12 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
US10924675B2 (en) | 2016-03-11 | 2021-02-16 | Apple Inc. | Optical image stabilization with voice coil motor for moving image sensor |
US11956544B2 (en) | 2016-03-11 | 2024-04-09 | Apple Inc. | Optical image stabilization with voice coil motor for moving image sensor |
US10437023B2 (en) | 2016-03-28 | 2019-10-08 | Apple Inc. | Folded lens system with three refractive lenses |
US10890734B1 (en) | 2017-03-29 | 2021-01-12 | Apple Inc. | Camera actuator for lens and sensor shifting |
US10863094B2 (en) | 2017-07-17 | 2020-12-08 | Apple Inc. | Camera with image sensor shifting |
US11122205B1 (en) | 2018-09-14 | 2021-09-14 | Apple Inc. | Camera actuator assembly with sensor shift flexure arrangement |
US11575835B2 (en) | 2020-09-24 | 2023-02-07 | Apple Inc. | Multi-axis image sensor shifting system |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9316727D0 (en) * | 1993-08-12 | 1993-09-29 | Inst Of Psychiatry | Models of alzheimers's disease |
WO1995019178A1 (en) | 1994-01-13 | 1995-07-20 | Research Foundation For Mental Hygiene, Inc. | Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders |
US6057117A (en) * | 1996-04-04 | 2000-05-02 | Chiron Corporation | Identification and use of selective inhibitors of glycogen synthase kinase 3 |
US6593512B1 (en) * | 1999-03-03 | 2003-07-15 | Cognosci, Inc. | Transgenic mouse expressing human tau gene |
AU6722300A (en) * | 1999-08-31 | 2001-03-26 | Ramot University Authority For Applied Research And Industrial Development Ltd. | Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders |
US6503914B1 (en) * | 2000-10-23 | 2003-01-07 | Board Of Regents, The University Of Texas System | Thienopyrimidine-based inhibitors of the Src family |
US20020172990A1 (en) * | 2002-02-19 | 2002-11-21 | Thomas Curran | Cyclin dependent kinase 5 phosphorylation of disabled 1 protein |
GB0314943D0 (en) * | 2003-06-25 | 2003-07-30 | Proteome Sciences Plc | Screening methods |
-
2003
- 2003-06-25 GB GBGB0314943.2A patent/GB0314943D0/en not_active Ceased
-
2004
- 2004-06-25 US US10/562,951 patent/US8822171B1/en active Active
- 2004-06-25 CA CA2527437A patent/CA2527437C/en not_active Expired - Fee Related
- 2004-06-25 AT AT04743090T patent/ATE404692T1/de active
- 2004-06-25 CA CA2848433A patent/CA2848433C/en not_active Expired - Fee Related
- 2004-06-25 DK DK04743090T patent/DK1636375T3/da active
- 2004-06-25 ES ES04743090T patent/ES2313032T3/es not_active Expired - Lifetime
- 2004-06-25 EP EP04743090A patent/EP1636375B1/de not_active Expired - Lifetime
- 2004-06-25 DE DE602004015791T patent/DE602004015791D1/de not_active Expired - Lifetime
- 2004-06-25 AU AU2004252273A patent/AU2004252273B2/en not_active Ceased
- 2004-06-25 WO PCT/GB2004/002739 patent/WO2005001114A2/en active IP Right Grant
- 2004-06-25 JP JP2006516474A patent/JP5688747B2/ja not_active Expired - Fee Related
-
2011
- 2011-11-25 JP JP2011257692A patent/JP2012045002A/ja not_active Withdrawn
-
2014
- 2014-07-24 US US14/339,538 patent/US20150051097A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP5688747B2 (ja) | 2015-03-25 |
ES2313032T3 (es) | 2009-03-01 |
CA2527437A1 (en) | 2005-01-06 |
CA2848433C (en) | 2017-01-10 |
AU2004252273A1 (en) | 2005-01-06 |
GB0314943D0 (en) | 2003-07-30 |
AU2004252273B2 (en) | 2011-04-28 |
DK1636375T3 (da) | 2008-12-15 |
CA2848433A1 (en) | 2005-01-06 |
JP2007527210A (ja) | 2007-09-27 |
EP1636375A2 (de) | 2006-03-22 |
WO2005001114A3 (en) | 2005-03-31 |
US20150051097A1 (en) | 2015-02-19 |
DE602004015791D1 (de) | 2008-09-25 |
CA2527437C (en) | 2016-08-02 |
EP1636375B1 (de) | 2008-08-13 |
US8822171B1 (en) | 2014-09-02 |
WO2005001114A2 (en) | 2005-01-06 |
JP2012045002A (ja) | 2012-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE404692T1 (de) | Screening-verfahren zur identifizierung von tau- protein modulierenden substanzen. | |
ATE468407T1 (de) | Verfahren zur identifizierung von proteinen mit stärkephosphorylierender enzymatischer aktivität | |
DE60041355D1 (de) | Verfahren zur detektion von erkrankungen | |
ATE504836T1 (de) | Verfahren zur identifizierung von trpv2- modulatoren | |
DE60328885D1 (de) | Verfahren zur Beurteilung eines Krankheitzustandes mittels Nachweis von partikel- und nicht partikelgebundenen Nukleinsäuren in Blutplasma und -serum | |
ATE417274T1 (de) | Verfahren zur identifizierung von mit zap-70 wechselwirkenden molekülen und zur zap-70- reinigung | |
ATE416385T1 (de) | Verfahren zur quantifizierung der phosphokinaseaktivität auf proteinen | |
ATE541054T1 (de) | Bio-barcode erkennung für zielmoleküle | |
ATE431854T1 (de) | Auf bio-barcodes beruhender nachweis von zielanalyten | |
ATE497164T1 (de) | Testverfahren zur messung der phosphorylierung | |
ATE324462T1 (de) | Assays zur detektierung von modulatoren der cytoskeletalen funktion | |
DE60324207D1 (de) | Verfahren zur identifizierung und/oder validierung von rezeptortyrosinkinase-inhibitoren | |
ATE345397T1 (de) | Verfahren zur isolierung von bakterien aus biologischen proben | |
ATE414701T1 (de) | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren | |
ATE533055T1 (de) | Verfahren zum screenen mithilfe von konformationsempfindlichen peptiden | |
ATE238551T1 (de) | Homogene nachweisverfahren zur bestimmung der phosphorylierungsaktivitäten von biologischem material | |
ATE221657T1 (de) | Entstörung durch rheumafaktoren | |
EP1138781A3 (de) | Methode zur Quantifizierung der Bindeaktivität von DNA-bindenden Proteinen | |
DE60010323D1 (de) | Fluoreszenzkorrelationsspektroskopie zur identifizierung von verbindung-ziel-bindung | |
DE602004011228D1 (de) | Verfahren und zusammensetzungen zur bestimmung glycierter proteine | |
DE602005018808D1 (de) | Odifizierung der supercoil-topologie von nukleinsäuren sowie modulatoren | |
DE60331669D1 (de) | Identifikation von Arzneimittel gegen Mykobakterien | |
ATE359513T1 (de) | Hochdurchsatzscreening von verbindungen für biologische wirksamkeit | |
ATE426807T1 (de) | Proteomanalyse verfahren zum drogen vergleich | |
ATE430317T1 (de) | Enzymatische messung von imatinib-mesylat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1636375 Country of ref document: EP |